Clinical Trial

Methamphetamine and Troriluzole

Study acronym: BED IN 46
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This will be a human laboratory study evaluating the influence of troriluzole treatment on the effects of methamphetamine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.
Trial Details
NCT Number NCT06989853
Lead Sponsor William Stoops
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Methamphetamine Use Disorder
Enrollment 40 participants
Start Date 2025-08-25
Primary Completion 2029-02-28 (estimated)
Study Completion 2029-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-08